Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 26.37
+0.42 (1.62%)
Feb 3, 2026, 1:25 PM CST
Guobang Pharma Revenue
Guobang Pharma had revenue of 1.44B CNY in the quarter ending September 30, 2025, a decrease of -5.39%. This brings the company's revenue in the last twelve months to 5.94B, up 4.00% year-over-year. In the year 2024, Guobang Pharma had annual revenue of 5.89B with 10.12% growth.
Revenue (ttm)
5.94B
Revenue Growth
+4.00%
P/S Ratio
2.41
Revenue / Employee
1.48M
Employees
4,003
Market Cap
14.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.89B | 541.39M | 10.12% |
| Dec 31, 2023 | 5.35B | -371.48M | -6.49% |
| Dec 31, 2022 | 5.72B | 1.22B | 26.98% |
| Dec 31, 2021 | 4.51B | 299.03M | 7.11% |
| Dec 31, 2020 | 4.21B | 404.28M | 10.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition